Ina Research Inc. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
420
499
145
237
916
Total Accounts Receivable
408
565
489
652
382
Inventories
724
423
460
509
692
Other Current Assets
219
181
28
67
92
Total Current Assets
1,771
1,667
1,121
1,466
2,082
Net Property, Plant & Equipment
2,334
2,312
1,490
1,386
1,324
Total Investments and Advances
1
-
-
-
-
Intangible Assets
46
22
7
4
3
Other Assets
36
34
32
32
33
Total Assets
4,186
4,062
2,650
2,888
3,442
ST Debt & Current Portion LT Debt
634
868
447
779
836
Accounts Payable
256
273
309
359
300
Income Tax Payable
27
6
7
15
30
Other Current Liabilities
686
438
390
433
823
Total Current Liabilities
1,604
1,585
1,152
1,586
1,989
Long-Term Debt
735
592
898
679
678
Provision for Risks & Charges
5
7
-
-
-
Deferred Taxes
-
27
-
-
-
Other Liabilities
51
53
51
51
48
Total Liabilities
2,395
2,237
2,101
2,316
2,715
Common Equity (Total)
1,732
1,755
524
561
709
Total Shareholders' Equity
1,732
1,755
524
561
709
Total Equity
1,791
1,825
548
572
727
Liabilities & Shareholders' Equity
4,186
4,062
2,650
2,888
3,442
Accumulated Minority Interest
60
70
25
11
17

About Ina Research

View Profile
Address
2148-188 Nishiminowa
Ina 399
Japan
Employees -
Website http://www.ina-research.co.jp
Updated 09/14/2018
Ina Research, Inc. engages in the development of pharmaceutical products. The company operates through Entrusted Testing and Environment segment. The Entrusted Testing segment covers the safe testing of pharmaceuticals, medical equipment, pesticides, food, and other chemicals and also handles the commissioned clinical trials for drug development.